On 2025-05-06, Prelude Therapeutics Incorporated (PRLD) announced earnings per share of $-0.42 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.47.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.45 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.47 | $-0.42 |
| 2025-03-10 | 2024-12-31 | $-0.49 | $-0.38 |
| 2024-11-06 | 2024-09-30 | $-0.48 | $-0.43 |
| 2024-08-12 | 2024-06-30 | $-0.46 | $-0.46 |
| 2024-05-07 | 2024-03-31 | $-0.47 | $-0.42 |
| 2024-02-15 | 2023-12-31 | $-0.50 | $-0.47 |
| 2023-11-01 | 2023-09-30 | $-0.58 | $-0.45 |
| 2023-08-03 | 2023-06-30 | $-0.65 | $-0.54 |
| 2023-05-08 | 2023-03-31 | $-0.68 | $-0.58 |
| 2023-03-15 | 2022-12-31 | $-0.63 | $-0.60 |
| 2022-11-14 | 2022-09-30 | $-0.63 | $-0.63 |
| 2022-08-09 | 2022-06-30 | $-0.60 | $-0.58 |
| 2022-05-10 | 2022-03-31 | $-0.68 | $-0.63 |
| 2022-03-16 | 2021-12-31 | $-0.69 | $-0.71 |
| 2021-11-12 | 2021-09-30 | $-0.62 | $-0.66 |
| 2021-08-12 | 2021-06-30 | $-0.51 | $-0.58 |
| 2021-05-11 | 2021-03-31 | $-0.41 | $-0.47 |
| 2021-03-16 | 2020-12-31 | -- | $-0.45 |
| 2020-11-10 | 2020-09-30 | $-0.35 | $-5.25 |